Article
An inactivating human TRPC6 channel mutation without focal segmental glomerulosclerosis.
Cellular and molecular life sciences : CMLS - 24 Aug 2023
Batool Lilas, Hariharan Krithika, Xu Yao, Kaßmann Mario, Tsvetkov Dmitry, Gohlke Björn-Oliver, Kaden Sylvia, Gossen Manfred, Nürnberg Bernd, Kurtz Andreas, Gollasch Maik
Abstract excerpt
Transient receptor potential cation channel-6 (TRPC6) gene mutations cause familial focal segmental glomerulosclerosis (FSGS), which is inherited as an autosomal dominant disease. In patients with TRPC6-related FSGS, all mutations map to the N- or C-terminal TRPC6 protein domains. Thus far, the majority of TRPC6 mutations are missense resulting in increased or decreased calcium influx; however, the fundamental...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
